| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Research &Development | SVP, Development | SVP, Development
1 company
Graham Richard A serves as a SVP, Research &Development at TBPH. Across recent SEC filings that breaks down to 0 buys and 14 sells. Those positions are worth an estimated $2.8M at current prices.
Historically, Graham Richard A's trades have earned a strong insider score of 71/100 across 13 rated trades. Over a 12-month horizon, 92.3% of those trades were profitable, with an average 12-month return of +9.9%.
The biggest single holding is TBPH (~$2.8M) as SVP, Research &Development. The recent filings there lean toward selling, a net 53,279 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 14, 2023 | TBPH Theravance Biopharma, Inc. | SVP, Research &Development | Sell | 2,482 | $10.22 | $25,366.04 | -0.7% | -16.7% | -6.0% | |
| Oct 16, 2023 | TBPH Theravance Biopharma, Inc. | SVP, Research &Development | Sell | 2,482 | $9.03 | $22,412.46 | -0.7% | +6.3% | -5.1% | |
| Sep 14, 2023 | TBPH Theravance Biopharma, Inc. | SVP, Research &Development | Sell | 2,482 | $9.89 | $24,546.98 | -0.7% | +13.4% | -16.2% | |
| Aug 11, 2023 | TBPH Theravance Biopharma, Inc. | SVP, Research &Development | Sell | 2,322 | $9.99 | $23,196.78 | -0.7% | +1.0% | -23.2% | |
| Jul 14, 2023 | TBPH Theravance Biopharma, Inc. | SVP, Research &Development | Sell | 2,322 | $9.84 | $22,848.48 | -0.7% | -6.2% | -4.3% | |
| Jun 14, 2023 | TBPH Theravance Biopharma, Inc. | SVP, Research &Development | Sell | 2,322 | $10.69 | $24,822.18 | -0.7% | -5.6% | -17.6% | |
| May 15, 2023 | TBPH Theravance Biopharma, Inc. | SVP, Research &Development | Sell | 2,322 | $11.26 | $26,145.72 | -0.6% | -10.6% | -16.6% | |
| Apr 14, 2023 | TBPH Theravance Biopharma, Inc. | SVP, Research &Development | Sell | 2,323 | $11.88 | $27,597.24 | -0.6% | -17.4% | -19.4% | |
| Mar 14, 2023 | TBPH Theravance Biopharma, Inc. | SVP, Research &Development | Sell | 2,323 | $10.32 | $23,973.36 | -0.6% | -0.7% | -17.1% | |
| Mar 6, 2023 | TBPH Theravance Biopharma, Inc. | SVP, Research &Development | Sell | 2,323 | $10.05 | $23,346.15 | -0.6% | +9.8% | -14.6% |